Cargando…

(31) Characterizing Stress and Sources of Information Related to Vaccination Against SARS-CoV-2 During Pregnancy

Detalles Bibliográficos
Autores principales:	De Souza, Larissa, Cantu-Weinstein, Ashley, Goje, Oluwatosin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646368/ http://dx.doi.org/10.1016/j.jaclp.2022.10.034

Ejemplares similares

Risk for Postpartum Depression Among Women Positive for COVID-19 During Pregnancy
por: Taljan, Katherine, et al.
Publicado: (2022)

Racial Disparities in Psychiatric Treatment Among Patients Positive for COVID-19 During Pregnancy
por: Cantu-Weinstein, Ashley, et al.
Publicado: (2022)

Factors influencing COVID-19 vaccination decision-making among pregnant and breastfeeding individuals
por: L, De souza, et al.
Publicado: (2023)

Risk for postpartum depressive symptoms among pregnant women in a tertiary care setting with and without a positive COVID-19 test
por: Taljan, Katherine E., et al.
Publicado: (2022)

Socioeconomic Status and Race Impact Maternal Morbidity Among Women Testing Positive for COVID-19
por: Cantu, Ashley, et al.
Publicado: (2022)

Optimizing mother–baby wellness during the 2019 coronavirus disease pandemic: A case for telemedicine
por: Markwei, Metabel, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic and Obstetrician and Gynecologist Workforce Distribution on Vaccine Deployment and Predicting Women’s Healthcare Shortages
por: Shastri, Toral, et al.
Publicado: (2021)

Mycoplasma genitalium: An Emerging Sexually Transmitted Infection
por: Munoz, Jessian L., et al.
Publicado: (2016)

Implementation of universal testing for severe acute respiratory syndrome coronavirus 2 in pregnant women with intended admission for delivery
por: Berkowitz, Kathleen M., et al.
Publicado: (2020)

SARS-CoV-2 vaccination in pregnancy
por: Dalcin, Daniel, et al.
Publicado: (2023)

371. Risk Factors for Non-Albicans Candidal Vulvovaginitis
por: Tressler, Andrea Boyd, et al.
Publicado: (2018)

2574. Temporal Changes in the Vaginal Microbiome During Treatment for Bacterial Vaginosis: Is Lactobacillus Iners an Important Player?
por: Shay, Elizabeth O, et al.
Publicado: (2019)

2576. The Microbiome of Recurrent Bacterial Vaginosis Compared with Asymptomatic Controls
por: Shay, Elizabeth O, et al.
Publicado: (2019)

Vaccines against SARS-COV-2
por: Kim, Jerome H.
Publicado: (2021)

Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy
por: Theiler, Regan N., et al.
Publicado: (2021)

The Benefits of Vaccination against SARS-CoV-2 during Pregnancy in Favor of the Mother/Newborn Dyad
por: Popescu, Daniela-Eugenia, et al.
Publicado: (2022)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2021)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2020)

Low Neutralizing Antibody Titers against the Mu Variant of SARS-CoV-2 in 31 BNT162b2 Vaccinated Individuals in Colombia
por: Álvarez-Díaz, Diego A., et al.
Publicado: (2022)

Levels of Neutralizing Antibodies against SARS-CoV-2 in Mothers and Neonates after Vaccination during Pregnancy
por: da Silva Filho, Antônio Oliveira, et al.
Publicado: (2023)

Reactogenicity, SARS-cov-2 infection, and pregnancy outcomes following COVID-19 vaccination during pregnancy in canada
por: E, Mcclymont, et al.
Publicado: (2023)

Microchimerism as a source of information on future pregnancies
por: Úbeda, Francisco, et al.
Publicado: (2023)

Timing vaccination against SARS-CoV-2
por: Barnoud, Coline, et al.
Publicado: (2021)

Dermatomyositis post vaccine against SARS-COV2
por: Camargo Coronel, Adolfo, et al.
Publicado: (2022)

SARS-CoV-2 infection and COVID-19 vaccination in pregnancy
por: Male, Victoria
Publicado: (2022)

Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report—IVY Network, February 1–August 31, 2022
por: Surie, Diya, et al.
Publicado: (2023)

SARS-CoV-2 epitopes inform future vaccination strategies
por: Shafqat, Areez, et al.
Publicado: (2022)

Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population
por: Weinberger, Birgit
Publicado: (2021)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

Recombinant protein vaccines against SARS-CoV-2
por: Gilbert, Sarah C, et al.
Publicado: (2021)

Messenger RNA vaccines against SARS-CoV-2
por: Topol, Eric J.
Publicado: (2021)

Development of an Inactivated Vaccine against SARS CoV-2
por: Pavel, Shaikh Terkis Islam, et al.
Publicado: (2021)

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

Acute Adverse Effects of Vaccines Against SARS-COV-2
por: Mahmood, Amina, et al.
Publicado: (2022)

Nucleic Acid Vaccines against SARS-CoV-2
por: Liu, Ying, et al.
Publicado: (2022)

The development of DNA vaccines against SARS-CoV-2
por: Khalid, Kanwal, et al.
Publicado: (2023)

SARS-CoV-2 Vaccination During Pregnancy: A Complex Decision
por: Wang, Elizabeth Wenqian, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity
por: Kalafat, Erkan, et al.
Publicado: (2021)

Generation and Characterization of a Nanobody Against SARS-CoV
por: Li, Jiang-Fan, et al.
Publicado: (2021)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3r1j4v0gkc868hil8vhbncpq1l